These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 19064801)

  • 1. Cell therapy for stroke: remaining issues to address before embarking on clinical trials.
    Borlongan CV
    Stroke; 2009 Mar; 40(3 Suppl):S146-8. PubMed ID: 19064801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Who's in favor of translational cell therapy for stroke: STEPS forward please?
    Chopp M; Steinberg GK; Kondziolka D; Lu M; Bliss TM; Li Y; Hess DC; Borlongan CV
    Cell Transplant; 2009; 18(7):691-3. PubMed ID: 19796499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stem cells in stroke repair: current success and future prospects.
    Gopurappilly R; Pal R; Mamidi MK; Dey S; Bhonde R; Das AK
    CNS Neurol Disord Drug Targets; 2011 Sep; 10(6):741-56. PubMed ID: 21838668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Step-up Approach for Cell Therapy in Stroke: Translational Hurdles of Bone Marrow-Derived Stem Cells.
    Glover LE; Tajiri N; Weinbren NL; Ishikawa H; Shinozuka K; Kaneko Y; Watterson DM; Borlongan CV
    Transl Stroke Res; 2012 Mar; 3(1):90-8. PubMed ID: 22389662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biotherapies in stroke.
    Detante O; Jaillard A; Moisan A; Barbieux M; Favre IM; Garambois K; Hommel M; Remy C
    Rev Neurol (Paris); 2014 Dec; 170(12):779-98. PubMed ID: 25459115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical trials of stroke therapy: which cells, which patients?
    Wechsler LR
    Stroke; 2009 Mar; 40(3 Suppl):S149-51. PubMed ID: 19064792
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell based therapies for ischemic stroke: from basic science to bedside.
    Liu X; Ye R; Yan T; Yu SP; Wei L; Xu G; Fan X; Jiang Y; Stetler RA; Liu G; Chen J
    Prog Neurobiol; 2014 Apr; 115():92-115. PubMed ID: 24333397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.
    Mangin G; Kubis N
    Stem Cell Rev Rep; 2019 Apr; 15(2):176-193. PubMed ID: 30443706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell therapy for stroke: emphasis on optimizing safety and efficacy profile of endothelial progenitor cells.
    Kaneko Y; Tajiri N; Shinozuka K; Glover LE; Weinbren NL; Cortes L; Borlongan CV
    Curr Pharm Des; 2012; 18(25):3731-4. PubMed ID: 22574986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone Marrow-Derived NCS-01 Cells Advance a Novel Cell-Based Therapy for Stroke.
    Brown J; Park YJ; Lee JY; Chase TN; Koga M; Borlongan CV
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concise Review: Stem Cell Therapy for Stroke Patients: Are We There Yet?
    Borlongan CV
    Stem Cells Transl Med; 2019 Sep; 8(9):983-988. PubMed ID: 31099181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neural stem cell therapy for subacute and chronic ischemic stroke.
    Boese AC; Le QE; Pham D; Hamblin MH; Lee JP
    Stem Cell Res Ther; 2018 Jun; 9(1):154. PubMed ID: 29895321
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transplantation for stroke.
    Roitberg B
    Neurol Res; 2004 Apr; 26(3):256-64. PubMed ID: 15142317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thrombolytic therapy within 3 to 6 hours after onset of ischemic stroke: useful or harmful?
    Ringleb PA; Schellinger PD; Schranz C; Hacke W
    Stroke; 2002 May; 33(5):1437-41. PubMed ID: 11988629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind placebo-controlled clinical evaluation of MultiStem for the treatment of ischemic stroke.
    Hess DC; Sila CA; Furlan AJ; Wechsler LR; Switzer JA; Mays RW
    Int J Stroke; 2014 Apr; 9(3):381-6. PubMed ID: 23692637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-Analysis of the Safety and Efficacy of Stem Cell Therapies for Ischemic Stroke in Preclinical and Clinical Studies.
    Ouyang Q; Li F; Xie Y; Han J; Zhang Z; Feng Z; Su D; Zou X; Cai Y; Zou Y; Tang Y; Jiang X
    Stem Cells Dev; 2019 Apr; 28(8):497-514. PubMed ID: 30739594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pluripotent stem cells in translation: a Food and Drug Administration-National Institutes of Health collaboration.
    Kleitman N; Rao MS; Owens DF
    Stem Cells Transl Med; 2013 Jul; 2(7):483-7. PubMed ID: 23757505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stem Cell Therapy as an Emerging Paradigm for Stroke (STEPS) II.
    Savitz SI; Chopp M; Deans R; Carmichael T; Phinney D; Wechsler L;
    Stroke; 2011 Mar; 42(3):825-9. PubMed ID: 21273569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stem Cell Therapy and Administration Routes After Stroke.
    Rodríguez-Frutos B; Otero-Ortega L; Gutiérrez-Fernández M; Fuentes B; Ramos-Cejudo J; Díez-Tejedor E
    Transl Stroke Res; 2016 Oct; 7(5):378-87. PubMed ID: 27384771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.